Trade show display company GLM Displays has recently redesigned their blog with integration into their main site.(PRWeb January 29, 2013)Read the full story at http://www.prweb.com/releases/GLMDisplays/blog/prweb10344889.htm

Study indicates migraines can be completely eliminated for majority of TMJ disorder sufferers by reducing nighttime teeth grinding and clenching…(PRWeb January 29, 2013)Read the full story at http://www.prweb.com/releases/migraines/TMJ_treatment/p…

Study indicates migraines can be completely eliminated for majority of TMJ disorder sufferers by reducing nighttime teeth grinding and clenching…(PRWeb January 29, 2013)Read the full story at http://www.prweb.com/releases/migraines/TMJ_treatment/p…

Spartan Bioscience partners with Medial for distribution in Czech Republic(PRWeb January 29, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10231751.htm

Dr. Summer L. James Serves San Antonio with Top IVF Care in New State-of-the-Art Fertility Center and Laboratory(PRWeb January 29, 2013)Read the full story at http://www.prweb.com/releases/2013/1/prweb10351911.htm

Industry and researchers in the photonics sector need to let their MEPs know just how vital the proposed Horizon 2020 research programme is to ensuring a strong future for Europe, say leaders of SPIE,…(PRWeb January 28, 2013)Read the full story at…

Burns Series B Surface Sensors are Designed for a Variety of Temperature Measurements Applications When an Immersion Sensor Just Won’t Work. Available in RTD and Thermocouple Models and Multiple…

(PRWeb January 28, 2013)

Read the full story at http://www.prweb.com/releases/2013/1/prweb10363223.htm

Selexis to meet with companies interested in technologies and services for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins.(PRWeb January 28, 2013)Read the full story at http://www.prweb.com/releases/BIO_A…

You might be surprised to find out which companies lead pharmaceutical industry drug approvals. This infographic from DrugPatentWatch shows that

BBL, recently acquired by Pacific BioLabs, contributed to a successful orphan drug Phase 3 trial of BioMarin’s GALNS for Morquio Syndrome.

(PRWeb January 28, 2013)

Read the full story at http://www.prweb.com/releases/2013/1/prweb10364528.htm